AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 137.1 SEK 0.22%
Market Cap: 16.7B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AddLife AB
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Total Equity
kr5B
CAGR 3-Years
38%
CAGR 5-Years
40%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Total Equity
kr3.1B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Total Equity
kr3.8B
CAGR 3-Years
52%
CAGR 5-Years
34%
CAGR 10-Years
23%
G
Genovis AB
STO:GENO
Total Equity
kr207.6m
CAGR 3-Years
32%
CAGR 5-Years
48%
CAGR 10-Years
22%
MedCap AB (publ)
STO:MCAP
Total Equity
kr1.2B
CAGR 3-Years
23%
CAGR 5-Years
30%
CAGR 10-Years
17%
M
Magle Chemoswed Holding AB
STO:MAGLE
Total Equity
kr158.2m
CAGR 3-Years
11%
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

AddLife AB
Glance View

Market Cap
16.7B SEK
Industry
Life Sciences Tools & Services

AddLife AB, a prominent player in the life sciences sector, intricately weaves its narrative through a commitment to enhancing healthcare and laboratory services across Europe. Founded in Sweden, the company has established itself as a crucial intermediary, effectively bridging the gap between manufacturers of medical devices and the healthcare institutions that require them. AddLife operates by acquiring and developing niche companies within two core segments: Labtech and Medtech. Through Labtech, it supplies essential equipment, instruments, and consumables for diagnostic and research laboratories. In Medtech, it provides a variety of healthcare logistics, medical products, and services to hospitals and care facilities, enhancing their operational efficiencies. The financial heartbeat of AddLife rests on its adeptness at creating value through strategic acquisitions and organic growth, capitalizing on the increasing demand for innovative healthcare solutions. By continuously expanding its product portfolio and enhancing the capabilities of its subsidiaries, AddLife ensures a diversified revenue stream, mitigating risks associated with dependence on any single product or market. This approach not only fortifies their market position but also fuels their profit margins, as they deftly respond to shifting industry demands and regulatory changes. The company's shared values and decentralized business model promote entrepreneurship within its subsidiaries, fostering an environment where innovation can thrive—ensuring their continued success and substantial contribution to the evolving landscape of healthcare.

ALIF B Intrinsic Value
158.15 SEK
Undervaluation 13%
Intrinsic Value
Price

See Also

What is AddLife AB's Total Equity?
Total Equity
5B SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Total Equity amounts to 5B SEK.

What is AddLife AB's Total Equity growth rate?
Total Equity CAGR 5Y
40%

Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for AddLife AB have been 38% over the past three years , 40% over the past five years .

Back to Top